We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current SRBT market cap is 179.4k. The company's latest EPS is USD -0.1629 and P/E is -2.27.
Year End December 30 2022 | 2021 | 2022 |
---|---|---|
USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 |
Operating Income | 0 | -79k |
Net Income | 0 | -79k |
Year End December 30 2022 | 2021 | 2022 |
---|---|---|
USD (US$) | USD (US$) | |
Total Assets | 0 | 18k |
Total Liabilities | 0 | 97k |
Total Equity | 0 | -79k |
Year End December 30 2022 | 2021 | 2022 |
---|---|---|
USD (US$) | USD (US$) | |
Operating | N/A | -77k |
Investing | N/A | N/A |
Financing | N/A | 95k |
Market Cap | 179.4k |
Price to Earnings Ratio | -2.27 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 9.97 |
Price to Book Ratio | -2.27 |
Dividend Yield | - |
Shares Outstanding | 484.85k |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 200 |
52 Week Change | 42.31% |
52 Week High | 0.90 |
52 Week Low | 0.1875 |
Spread (Intraday) | 0.96 (91.07%) |
Company Name | Shanrong Biotechnology Corporation (PK) |
Address |
1333 north buffalo drive, suite 210 las vegas, nevada 89128 |
Website | https://www.srbtmerger.com |
Industry | ordnance & accessories, nec (3489) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions